Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group.
Jeger RV, Eccleshall S, Wan Ahmad WA, Ge J, Poerner TC, Shin ES, Alfonso F, Latib A, Ong PJ, Rissanen TT, Saucedo J, Scheller B, Kleber FX; International DCB Consensus Group.
JACC Cardiovasc Interv. 2020 Jun 22;13(12):1391-1402. doi: 10.1016/j.jcin.2020.02.043. Epub 2020 May 27.
Definite stent thrombosis after drug-eluting stent implantation in coronary bifurcation lesions: A meta-analysis of 3,107 patients from 14 randomized trials.
Zhou Y, Chen S, Huang L, Hildick-Smith D, Ferenc M, Jabbour RJ, Azzalini L, Colombo A, Chieffo A, Zhao X.
Catheter Cardiovasc Interv. 2018 Oct 1;92(4):680-691. doi: 10.1002/ccd.27443. Epub 2017 Dec 7.
Single versus double stenting for unprotected left main coronary artery bifurcation lesions: a systematic review and meta-analysis.
Karrowni W, Makki N, Dhaliwal AS, Vyas A, Blevins A, Dughman S, Girotra S, Cram P, Horwitz PA.
J Invasive Cardiol. 2014 Jun;26(6):229-33.
Clinical outcomes of coronary artery bifurcation disease patients underwent Culotte two-stent technique: a single center experience.
Chang CF, Chang KH, Lai CH, Lin TH, Liu TJ, Lee WL, Su CS.
BMC Cardiovasc Disord. 2019 Sep 2;19(1):208. doi: 10.1186/s12872-019-1192-2.
Clinical outcomes of a dedicated bifurcation stent system.
Sivalingam J, Mazhar MW, Chaddad RA, Fouladvand F, Cortese B.
Cardiovasc Revasc Med. 2024 Feb;59:21-26. doi: 10.1016/j.carrev.2023.08.015. Epub 2023 Aug 31.
[Interventional cardiology].
Albarrán A, Pinar E, Baz JA, Mauri J.
Rev Esp Cardiol. 2008 Feb;61 Suppl 1:72-85.
Drug-coated balloon in the treatment of coronary bifurcation lesions: A hope or hype?
Dash D, Mody R, Ahmed N, Malan SR, Mody B.
Indian Heart J. 2022 Nov-Dec;74(6):450-457. doi: 10.1016/j.ihj.2022.10.193. Epub 2022 Nov 5.
Patterns of Restenosis After Left Main Bifurcation Single- or Dual-Stenting: An EBC MAIN Trial Subanalysis.
Maznyczka A, Arunothayaraj S, Banning AP, Schmitz T, Wlodarczak A, Silvestri M, Egred M, Koning R, Spence MS, Morice MC, Lefevre T, Ferenc M, Cockburn J, Erglis A, Brunel P, Burzotta F, Kretov E, Hovasse T, Pan M, Clesham G, Chieffo A, Mylotte D, Lindsay M, Christiansen EH, Bouisset F, Vaquerizo B, Lassen JF, Darremont O, Louvard Y, Stankovic G, Hildick-Smith D; EBC MAIN (European Bifurcation Club Left Main Coronary Stent) Trial Investigators.
Circ Cardiovasc Interv. 2025 Nov;18(11):e015546. doi: 10.1161/CIRCINTERVENTIONS.125.015546. Epub 2025 Sep 17.
Coronary bifurcation lesion treatment with the BioMime Branch sirolimus-eluting coronary side-branch stent system: A single-center experience.
Bartorelli AL, Monizzi G, Grancini L, Gallinoro E, Mastrangelo A, Mallia V, Fabbiocchi F.
Cardiovasc Revasc Med. 2025 Jun;75:39-45. doi: 10.1016/j.carrev.2024.08.018. Epub 2024 Aug 28.
Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trial.
Suzuki N, Angiolillo DJ, Tannenbaum MA, Driesman MH, Smith C, Bikkina M, Meckel CR, Morales CE, Xenopoulos NP, Coletta JE, Bezerra HG, Bass TA, Costa MA.
Catheter Cardiovasc Interv. 2009 Jun 1;73(7):890-7. doi: 10.1002/ccd.21796.
